« Return to News | Clinical Intelligence | CROs/Service Providers

PPD shareholders approve merger with The Carlyle Group, Hellman & Friedman

Thursday, December 1, 2011 11:06 AM

PPD has reported that its shareholders have voted to approve the adoption of the agreement and plan of merger, providing for the merger of the company with an entity controlled by affiliates of The Carlyle Group and affiliates of Hellman & Friedman.

Approximately 96.4% of the shares voted in favor of the adoption of the merger agreement, which represented approximately 75.6% of the company's total outstanding shares of common stock as of the October 24, 2011 record date. A quorum of 78.4% of the company's total outstanding shares of common stock as of the October 24, 2011 record date voted at the meeting.

Upon consummation of the merger, the company's shareholders will receive $33.25 in cash for each share of the company's common stock. The transaction is subject to certain remaining customary closing conditions as set forth in the merger agreement and discussed in detail in the definitive proxy statement filed with the U.S. Securities and Exchange Commission by PPD.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.